Professor | Yonggang Zhou | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Yonggang Zhou
Contact Information	ygzhou@ustc.edu.cn
Language ability	English, Chinese
Province	Anhui

Upload Avatar (500 x 500)

Name

Yonggang Zhou

Contact Information

ygzhou@ustc.edu.cn

Language ability

English, Chinese

Province

Anhui

University/Lab Affiliation and Title	University of Science and Technology of China
Faculty	Basic Medical Sciences
Academic Background & Achievements	2018 - PhD in Immunology: University of Science and Technology of China 2020 - Awarded 'Outstanding Doctoral Dissertation' by the Chinese Academy of Sciences 2020 - Received 'Anhui Youth May Fourth Medal' 2020 - Selected as 'Mozi Outstanding Youth' at USTC
Work Experience	2018-2020 - University of Science and Technology of China, School of Life Sciences and Medicine, Postdoctoral Researcher 2018-2021 - University of Science and Technology of China, School of Life Sciences and Medicine, Special Associate Researcher
Awards	2020: Anhui Youth May Fourth Medal 2020: Outstanding Doctoral Dissertation by the Chinese Academy of Sciences 2020: Mozi Outstanding Youth at USTC

University/Lab Affiliation and Title

University of Science and Technology of China

Faculty

Basic Medical Sciences

Academic Background & Achievements

2018 - PhD in Immunology: University of Science and Technology of China
2020 - Awarded 'Outstanding Doctoral Dissertation' by the Chinese Academy of Sciences
2020 - Received 'Anhui Youth May Fourth Medal'
2020 - Selected as 'Mozi Outstanding Youth' at USTC

Work Experience

2018-2020 - University of Science and Technology of China, School of Life Sciences and Medicine, Postdoctoral Researcher
2018-2021 - University of Science and Technology of China, School of Life Sciences and Medicine, Special Associate Researcher

Awards

2020: Anhui Youth May Fourth Medal
2020: Outstanding Doctoral Dissertation by the Chinese Academy of Sciences
2020: Mozi Outstanding Youth at USTC

Areas of Focus	Mechanisms of uterine NK cells in promoting early embryonic development Transcriptional regulation of NK cells and disease mechanisms Immunotherapy targeting reproductive immune microenvironment for pregnancy-related diseases
Publications	PBX1 expression in uterine natural killer cells drives fetal growth., Zhou Y, Fu B, Xu X, Zhang J, Tong X, Wang Y, Dong Z, Zhang X, Shen N, Zhai Y, Kong X, Sun R, Tian Z, Wei H., 2020 Natural killer cells promote fetal development through the secretion of growth-promoting factors., Fu B#, Zhou Y#, Ni X#, Tong X, Xu X, Dong Z, Sun R, Tian Z, Wei H., 2017 Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients., Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, Sun R, Tian Z, Xu X, Wei H., 2020 Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status., Zhou Y, Zhang J, Wang D, Guan W, Qin J, Xu X, Fang J, Fu B, Zheng X, Wang D, Zhao H, Chen X, Tian Z, Xu X, Wang G, Wei H., 2021 Tocilizumab is recommended for the treatment of severe COVID-19., Zhou Y, Wei H., 2020

Areas of Focus

Mechanisms of uterine NK cells in promoting early embryonic development
Transcriptional regulation of NK cells and disease mechanisms
Immunotherapy targeting reproductive immune microenvironment for pregnancy-related diseases

Publications

PBX1 expression in uterine natural killer cells drives fetal growth., Zhou Y, Fu B, Xu X, Zhang J, Tong X, Wang Y, Dong Z, Zhang X, Shen N, Zhai Y, Kong X, Sun R, Tian Z, Wei H., 2020
Natural killer cells promote fetal development through the secretion of growth-promoting factors., Fu B#, Zhou Y#, Ni X#, Tong X, Xu X, Dong Z, Sun R, Tian Z, Wei H., 2017
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients., Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, Sun R, Tian Z, Xu X, Wei H., 2020
Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status., Zhou Y, Zhang J, Wang D, Guan W, Qin J, Xu X, Fang J, Fu B, Zheng X, Wang D, Zhao H, Chen X, Tian Z, Xu X, Wang G, Wei H., 2021
Tocilizumab is recommended for the treatment of severe COVID-19., Zhou Y, Wei H., 2020

Nk Cells Embryonic Development Transcriptional Regulation Disease Mechanisms Immunotherapy Reproductive Immunology Pregnancy Immune Microenvironment Inflammation Pathology

Cheng Liqin - Central South University

Liang Wang - Zhejiang University

Jianzhong Chen - Zhejiang University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us